Leonard Singleton Mark's Insider Trades & SAST Disclosures
Leonard Singleton Mark's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 3,875 Class A Common Stock done at an average price of $7.6 . Disclosure was reported to the exchange on April 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leonard Singleton Mark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 7.57 per share. | 11 Apr 2025 | 3,875 | 141,088 (0%) | 0% | 7.6 | 29,334 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 13,000 | 144,963 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2025 | 13,000 | 26,000 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 9.79 per share. | 24 Mar 2025 | 5,479 | 131,963 (0%) | 0% | 9.8 | 53,639 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 18,625 | 18,625 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 18,625 | 137,442 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 10.19 per share. | 18 Feb 2025 | 6,498 | 118,817 (0%) | 0% | 10.2 | 66,215 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 20,153 | 125,315 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 20,153 | 60,457 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 23 Dec 2024 | 10,733 | 105,162 (0%) | 0% | 10.5 | 113,018 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Leonard Singleton Mark | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 31,000 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Singleton Leonard | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 31,000 | 115,895 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 5.57 per share. | 21 Jun 2024 | 9,219 | 84,895 (0%) | 0% | 5.6 | 51,350 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 31,000 | 94,114 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 31,000 | 31,000 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 17 Jun 2024 | 13,753 | 63,114 (0%) | 0% | 5.8 | 80,318 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 42,202 | 76,867 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 42,202 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 11 Apr 2024 | 4,000 | 34,665 (0%) | 0% | 4.8 | 19,000 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 13,000 | 38,665 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 13,000 | 39,000 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 18,625 | 31,206 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 18,625 | 37,250 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 21 Mar 2024 | 5,541 | 25,665 (0%) | 0% | 5.4 | 29,853 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 181,980 | 181,980 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 80,610 | 80,610 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 42,202 | 42,202 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 62,000 | 62,000 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 135,800 | 135,800 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 52,000 | 52,000 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 24 Mar 2023 | 6,044 | 12,581 (0%) | 0% | 1.3 | 7,676 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 18,625 | 18,625 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 18,625 | 55,875 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 223,200 | 223,200 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Mark Leonard Singleton | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 74,500 | 74,500 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges